Hennessy Cap Financials
This page shows Hennessy Cap (HVIIU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Hennessy Cap's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
With a current ratio of 6.82, Hennessy Cap holds $6.82 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Key Financial Metrics
Earnings & Revenue
Hennessy Cap reported $576K in net income in fiscal year 2026. This represents a decrease of 84.4% from the prior year.
Cash & Balance Sheet
Hennessy Cap held $323K in cash against $0 in long-term debt as of fiscal year 2026.
Margins & Returns
Capital Allocation
HVIIU Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.1M | N/A | $819K+82.5% | $449K-8.2% | $489K+919.8% | $48K |
| Operating Income | -$1.1M | N/A | -$819K-82.5% | -$449K+8.2% | -$489K-919.8% | -$48K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $576K | N/A | $1.2M-21.6% | $1.5M+49.4% | $1.0M+2223.0% | -$48K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A |
HVIIU Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|
| Total Assets | $199.3M+0.5% | $198.3M+0.7% | $196.9M+0.8% | $195.3M+0.8% | $193.7M+19402.2% | $993K |
| Current Assets | $703K-47.0% | $1.3M-21.9% | $1.7M-14.3% | $2.0M-10.3% | $2.2M+5313.7% | $41K |
| Cash & Equivalents | $323K-67.2% | $984K-39.3% | $1.6M-12.8% | $1.9M-9.0% | $2.0M+10118.9% | $20K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $209.4M+1.0% | $207.3M+1.6% | $204.2M+1.2% | $201.8M+1.0% | $199.9M+19570.0% | $1.0M |
| Current Liabilities | $103K-68.5% | $327K+92.5% | $170K+8.4% | $157K+7.8% | $145K-74.3% | $566K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$10.1M-11.4% | -$9.1M-24.7% | -$7.3M-10.8% | -$6.5M-6.0% | -$6.2M-26832.3% | -$23K |
| Retained Earnings | -$10.1M-11.4% | -$9.1M-24.7% | -$7.3M-10.8% | -$6.6M-6.0% | -$6.2M-12792.5% | -$48K |
HVIIU Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$645K+12.1% | -$734K-117.3% | -$338K-4.4% | -$323K+33.8% | -$489K-1279.4% | -$35K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $59K-38.3% | $95K-4.1% | $99K-29.2% | $140K+100.1% | -$190.0M | N/A |
| Financing Cash Flow | -$75K | $0 | $0 | $0-100.0% | $192.5M+347270.6% | $55K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A |
HVIIU Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 0.3% | N/A | 0.6%-0.2pp | 0.8%+0.2pp | 0.5%+5.4pp | -4.8% |
| Current Ratio | 6.82+2.8 | 4.06-5.9 | 10.00-2.7 | 12.65-2.6 | 15.21+15.1 | 0.07 |
| Debt-to-Equity | -20.76+2.1 | -22.91+5.2 | -28.14+2.7 | -30.82+1.5 | -32.34+11.9 | -44.28 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$10.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
Is Hennessy Cap profitable?
Yes, Hennessy Cap (HVIIU) reported a net income of $576K in fiscal year 2026.
What are Hennessy Cap's total assets?
Hennessy Cap (HVIIU) had $199.3M in total assets as of fiscal year 2026, including both current and long-term assets.
What is Hennessy Cap's current ratio?
Hennessy Cap (HVIIU) had a current ratio of 6.82 as of fiscal year 2026, which is generally considered healthy.
What is Hennessy Cap's debt-to-equity ratio?
Hennessy Cap (HVIIU) had a debt-to-equity ratio of -20.76 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Hennessy Cap's return on assets (ROA)?
Hennessy Cap (HVIIU) had a return on assets of 0.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Why is Hennessy Cap's debt-to-equity ratio negative or unusual?
Hennessy Cap (HVIIU) has negative shareholder equity of -$10.1M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
How financially healthy is Hennessy Cap?
Hennessy Cap (HVIIU) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.